Sorted By:

Relevance


Improve Access to Out of Pocket Cost Information

PhRMA  |  Video

One policy solution for delivering innovative treatments to patients is to engage and empower consumers by making more information about health care out-of-pocket costs available.
https://www.phrma.org/video/improve-access-to-out-of-pocket-cost-information

Stopping Ebola

PhRMA  |  From PhRMA

WHO on Ebola CDC on Ebola NIH on Ebola IFPMA on Ebola RxResponse on Ebola White House Response to Ebola IFPMA: Ebola Capacity Building Page EFPIA & IMI Announce Collaborative Efforts Against Ebola Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans.
https://www.phrma.org/science/how-far-we-ve-come/progress-in-treating-disease/stopping-ebola

Drug Importation

PhRMA  |  From PhRMA

Four years later, the program was deemed a failure and terminated.   
https://www.phrma.org/advocacy/safety/drug-importation

Who Has a Seat at ICER's Table?

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/who-has-a-seat-at-icer-s-table

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

PhRMA  |  Press Release

Adequate fuel supplies would help ensure generator power is maintained (until electrical power is fully restored) and that vehicles on the island are able to transport supplies and employees.
https://www.phrma.org/press-release/phrma-letter-to-puerto-rico-secretary-of-economic-development-and-commerce

Associate Vice President – Science and Regulatory Advocacy (Biologics and Biosimilars Advocacy)

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/associate-vice-president-science-and-regulatory-advocacy-biologics-and-biosimilars-advocacy

Do Not Go Gentle. #GOBOLDLY

PhRMA  |  Video

Finding lifesaving medicines is a life’s work – the work of 140,000 researchers who never say never.
https://www.phrma.org/video/do-not-go-gentle-goboldly

Thair Phillips

PhRMA  |  Biography

He now serves as RetireSafe’s President, an organization of 400,000 nationwide supporters dedicated to preserving the options and benefits of older Americans through advocacy, education, and the power of free markets.
https://www.phrma.org/biography/thair-phillips

Biopharmaceutical Industry Speakers List

PhRMA  |  From PhRMA

Our Industry Speakers List contains names of executives at PhRMA and from our member companies available to participate in events and panel discussions on the cost and value of prescription medicines.
https://www.phrma.org/press-room/biopharmaceutical-industry-speakers-list1

Daniel M. Price

PhRMA  |  Biography

He currently serves on the Panel of Arbitrators of the World Bank’s International Centre for Settlement of Investment Disputes, the Advisory Board of the Atlantic Council, and the Board of Directors of the American Arbitration Association. 
https://www.phrma.org/biography/daniel-m-price

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

PhRMA  |  Blog Post

The rapid pace of scientific advances has helped usher in a new era of medicine for cancer patients over the last decade.
http://catalyst.phrma.org/phrma-member-companies-and-nih-create-public-private-partnership-for-immuno-oncology

Protect Your Health: Important Disaster Preparedness Tips for Harvey and Irma

PhRMA  |  Blog Post

It’s best to drink bottled water and to always boil or disinfect water before using it to clean clothes or dishes.
http://catalyst.phrma.org/protect-your-health-important-disaster-preparedness-tips-for-harvey-and-irma

Manager - Public Affairs

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/manager-public-affairs

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

PhRMA  |  Blog Post

We also need to ensure patients receive more of the benefit of price negotiations between biopharmaceutical companies and payers.
http://catalyst.phrma.org/phrma-ceo-in-forbes-how-to-negotiate-better-deals-for-prescription-medicines

Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation

PhRMA  |  Blog Post

The two will offer their perspective on how the focus toward innovation and discovery happening within the Bay Area – and throughout California – has the power to transform medicine and treatments, and the millions of patients who could potentially benefit.
http://catalyst.phrma.org/putting-the-bio-in-biotech-how-bay-area-minds-are-powering-biopharmaceutical-innovation

Growing consensus on the need to improve communications with health care professionals

PhRMA  |  Blog Post

This type of information will further provide sophisticated payers and health care professionals with the best possible knowledge for determining treatment options and choices.
http://catalyst.phrma.org/growing-consensus-on-the-need-to-improve-communications-with-health-care-professionals

PhRMA Statement Regarding Benefits of U.S. Innovation

PhRMA  |  Press Release

Foreign government price controls, according to independent research, chill innovation, impede patients’ access to the newest cutting-edge medicines, and trigger innovators to relocate to countries with more progressive public policy.
https://www.phrma.org/press-release/phrma-statement-regarding-benefits-of-u-s-innovation

Vice President, Public Affairs

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org

Scott LaGanga to Lead PhRMA State Advocacy; Shannon Graham to Lead Strategic Alliances

PhRMA  |  Press Release

“I look forward to him leveraging this experience and the power of our state advocacy organization to lead us through some of the most important work we have to do.”
https://www.phrma.org

Medicare Monday: What they’re saying about the CMS proposed Part B payment model

PhRMA  |  Blog Post

Also, rheumatologists argue that factoring in the Part B demonstration would distort physician comparisons in the Merit-Based Incentive Payment System, which will also be part of the new physician-pay scheme,” reports Inside Health Policy.
http://catalyst.phrma.org/medicare-monday-what-theyre-saying-about-the-cms-proposed-part-b-payment-model

Follow the Dollar Executive Summary

PhRMA  |  Report

Drawing from published materials and interviews with industry experts, this paper explains the financial flows that occur as brand medicines move through the supply chain for retail, mail-order, and specialty drugs.
https://www.phrma.org

Paying for Personalized Medicine: Protecting the Future of Patient-Centered Cancer Care

PhRMA  |  Blog Post

The initiative aims to bring together the cancer community and has developed policy recommendations that will foster innovation in cancer care and research.
http://catalyst.phrma.org/paying-for-personalized-medicine-protecting-the-future-of-patient-centered-cancer-care

Contact PhRMA

PhRMA  |  From PhRMA

PhRMA’s mission to effectively advocate for public policy that encourages innovative drug development, drug discovery and drug research in the biopharmaceutical industry would not be possible without participation and interest from people like you.
https://www.phrma.org/contact-us

How biopharmaceutical collaboration is driving a new era of medicine

PhRMA  |  Blog Post

As stakeholders across the R&D ecosystem are increasingly coming together to tackle sciences’ most vexing health challenges, .deloitte.com/us/en/pages/life-sciences-and-health-care/articles/how-biopharma-collaborations-are-fueling-biomedical-innovation.html?
http://catalyst.phrma.org/collaboration-driving-new-era-of-medicine

Helping those affected by the 2017 hurricane season

PhRMA  |  Blog Post

Lastly, Novartis’ associate donations will be matched $1 for $1 with a maximum of $5,000 per associate per year across all giving programs.
http://catalyst.phrma.org/helping-those-affected-by-hurricane-harvey

You have reviewed the first 200 results out of 1102. Each page contains 25 results. You're on page 8.

prev 7 8 9 10 11 12 next